［1］洪明晃，郭翔. 鼻咽癌［M］. 北京:中国医药科技出版社,2003：16-26.
［2］Ji MF, Wang DK, Yu YL, et al. Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma［J］. Br J Cancer,2007,96(4):623-630.
［3］Ng MH, Chan KH, Ng SP, et al. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma［J］. Ai Zheng,2006,25(2):250-256.
［4］季明芳，郭媛卿，梁锦胜，等. 鼻咽癌患者发病前后EB病毒VCA/IgA和EA/IgA滴度动态分析［J］. 中华肿瘤杂志,2003,25(3):39-41.
［5］Liu Y, Huang Q, Liu W, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China［J］. Int J Cancer,2012,131(2):406-416.
［6］卫生部疾病预防控制局，癌症早诊早治项目专家委员会. 中国癌症筛查及早诊早治技术方案(2011年版)［M］. 北京:人民卫生出版社,2011：144-171.
［7］Zeng Y, Zhang LG, Li HY, et al. Serological mass survey for early detection of nasopharyngeal carcinoma in Wuzhou City, China［J］. Int J Cancer,1982,29(2):139-141.
［8］Zong YS, Sham JS, Ng MH, et al. Immunoglobulin a against viral capsid antigen of Epstein-Barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma［J］. Cancer,1992,69(1):3-7.
［9］Zeng Y, Zhong JM, Li LY, et al. Follow-up studies on Epstein-Barr virus IgA/VCA antibody-positive persons in Cangwu County, China［J］. Intervirology,1983,20(4):190-194.
［10］季明芳，郑受昂，郭媛卿，等. 中山市鼻咽癌高发现场13年前瞻性研究［J］. 肿瘤,2003,23(4):272-274.
［11］Cao SM, Chen SH, Qian CN, et al. Familial nasopharyngeal carcinomas possess distinguished clinical characteristics in southern China［J］. Chin J Cancer Res,2014,26(5):543-549.
［12］曾毅，刘育希，刘纯仁，等. 应用免疫酶法和免疫放射自显影法普查鼻咽癌［J］. 广西卫生,1979,1(2):16-20. |
